Microbix Launches New Products to Support H3N2 Flu Testing

Stock Information for Cardiol Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cardiol Therapeutics Inc.

Microbix Schedules Release of Results for Q4 Fiscal 2025
Microbix Announces Initiation of Normal Course Issuer Bid
Microbix & Seegene Mexico Collaborate to Improve Test Accuracy
Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests
Microbix Addresses Cybersecurity Incident
Microbix Presenting at Muskoka Capital Event
Microbix Assisting EMQN with Second Genetic-Test EQA Program
Microbix Client Labquality Introduces Novel EQA Scheme at ESCV

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.